Cargando…
High-risk additional cytogenetic aberrations in a Dutch chronic phase chronic myeloid leukemia patient population
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620565/ https://www.ncbi.nlm.nih.gov/pubmed/36951166 http://dx.doi.org/10.3324/haematol.2022.282447 |
| _version_ | 1785130233048858624 |
|---|---|
| author | Kockerols, Camille C.B. Geelen, Inge G.P. Levin, Mark-David Janssen, Jeroen J.W.M. Beverloo, H. Berna Dinmohamed, Avinash G. Hoogendoorn, Mels Cornelissen, Jan J. Westerweel, Peter E. |
| author_facet | Kockerols, Camille C.B. Geelen, Inge G.P. Levin, Mark-David Janssen, Jeroen J.W.M. Beverloo, H. Berna Dinmohamed, Avinash G. Hoogendoorn, Mels Cornelissen, Jan J. Westerweel, Peter E. |
| author_sort | Kockerols, Camille C.B. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10620565 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106205652023-11-03 High-risk additional cytogenetic aberrations in a Dutch chronic phase chronic myeloid leukemia patient population Kockerols, Camille C.B. Geelen, Inge G.P. Levin, Mark-David Janssen, Jeroen J.W.M. Beverloo, H. Berna Dinmohamed, Avinash G. Hoogendoorn, Mels Cornelissen, Jan J. Westerweel, Peter E. Haematologica Letter to the Editor Fondazione Ferrata Storti 2023-03-23 /pmc/articles/PMC10620565/ /pubmed/36951166 http://dx.doi.org/10.3324/haematol.2022.282447 Text en Copyright© 2023 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letter to the Editor Kockerols, Camille C.B. Geelen, Inge G.P. Levin, Mark-David Janssen, Jeroen J.W.M. Beverloo, H. Berna Dinmohamed, Avinash G. Hoogendoorn, Mels Cornelissen, Jan J. Westerweel, Peter E. High-risk additional cytogenetic aberrations in a Dutch chronic phase chronic myeloid leukemia patient population |
| title | High-risk additional cytogenetic aberrations in a Dutch chronic phase chronic myeloid leukemia patient population |
| title_full | High-risk additional cytogenetic aberrations in a Dutch chronic phase chronic myeloid leukemia patient population |
| title_fullStr | High-risk additional cytogenetic aberrations in a Dutch chronic phase chronic myeloid leukemia patient population |
| title_full_unstemmed | High-risk additional cytogenetic aberrations in a Dutch chronic phase chronic myeloid leukemia patient population |
| title_short | High-risk additional cytogenetic aberrations in a Dutch chronic phase chronic myeloid leukemia patient population |
| title_sort | high-risk additional cytogenetic aberrations in a dutch chronic phase chronic myeloid leukemia patient population |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620565/ https://www.ncbi.nlm.nih.gov/pubmed/36951166 http://dx.doi.org/10.3324/haematol.2022.282447 |
| work_keys_str_mv | AT kockerolscamillecb highriskadditionalcytogeneticaberrationsinadutchchronicphasechronicmyeloidleukemiapatientpopulation AT geeleningegp highriskadditionalcytogeneticaberrationsinadutchchronicphasechronicmyeloidleukemiapatientpopulation AT levinmarkdavid highriskadditionalcytogeneticaberrationsinadutchchronicphasechronicmyeloidleukemiapatientpopulation AT janssenjeroenjwm highriskadditionalcytogeneticaberrationsinadutchchronicphasechronicmyeloidleukemiapatientpopulation AT beverloohberna highriskadditionalcytogeneticaberrationsinadutchchronicphasechronicmyeloidleukemiapatientpopulation AT dinmohamedavinashg highriskadditionalcytogeneticaberrationsinadutchchronicphasechronicmyeloidleukemiapatientpopulation AT hoogendoornmels highriskadditionalcytogeneticaberrationsinadutchchronicphasechronicmyeloidleukemiapatientpopulation AT cornelissenjanj highriskadditionalcytogeneticaberrationsinadutchchronicphasechronicmyeloidleukemiapatientpopulation AT westerweelpetere highriskadditionalcytogeneticaberrationsinadutchchronicphasechronicmyeloidleukemiapatientpopulation |